Note Agreements in the Pharmaceuticals Industry

1,725 Contracts & Agreements

Browse by Company

4Front Ventures Corp. (3 contracts)
60 DEGREES PHARMACEUTICALS, INC. (29)
Acacia Diversified Holdings, Inc. (1)
Acasti Pharma Inc. (8)
Accelerated Pharma, Inc. (8)
Acer Therapeutics Inc. (12)
ACHILLION PHARMACEUTICALS INC (7)
Acreage Holdings, Inc. (2)
ACURA PHARMACEUTICALS, INC (20)
Adamis Pharmaceuticals Corp (17)
ADIAL PHARMACEUTICALS, INC. (9)
Aegerion Pharmaceuticals, Inc. (8)
AEOLUS PHARMACEUTICALS, INC. (5)
AEON Biopharma, Inc. (8)
AERIE PHARMACEUTICALS INC (2)
Aerpio Pharmaceuticals, Inc. (4)
AGILE THERAPEUTICS INC (2)
Akers Biosciences, Inc. (3)
AKESIS PHARMACEUTICALS, INC. (1)
Akorn (6)
Alexza Pharmaceuticals Inc. (8)
ALIMERA SCIENCES INC (1)
Allergan, plc (1)
ALSERES PHARMACEUTICALS INC (28)
Altus Pharmaceuticals Inc. (4)
Amag Pharmaceuticals (2)
AmeriCann, Inc. (5)
Amphastar Pharma (1)
Ampio Pharmaceuticals, Inc. (6)
AMYLIN PHARMACEUTICALS INC (6)
Angion Biomedica Corp. (4)
ANGIOTECH PHARMACEUTICALS INC (4)
ANI Pharma Inc (1)
Apimeds Pharmaceuticals US, Inc. (10)
Applied BioSciences Corp. (5)
APRICUS BIOSCIENCES, INC. (18)
Aquestive Therapeutics, Inc. (2)
ARADIGM CORP (6)
Aralez Pharmaceuticals Inc. (15)
ARIAD PHARMACEUTICALS INC (5)
ARTELO BIOSCIENCES, INC. (2)
Artemis Therapeutics, Inc. (3)
Assertio Therapeutics, Inc (7)
Astex Pharmaceuticals, Inc (3)
AUXILIUM PHARMACEUTICALS INC (1)
AVALON PHARMACEUTICALS INC (3)
AVENUE THERAPEUTICS, INC. (1)
AXIM BIOTECHNOLOGIES, INC. (13)
AYTU BIOSCIENCE, INC (7)
Bakhu Holdings, Corp. (2)
Barrel Energy Inc. (2)
Baudax Bio, Inc. (1)
Bespoke Extracts, Inc. (4)
Big Rock Partners Acquisition Corp. (12)
BIODELIVERY SCIENCES INTERNATIONAL INC (17)
Biofrontera Inc. (1)
BioPharmX Corp (6)
Blue Water Acquisition Corp. (2)
BODY & MIND INC. (4)
Bohai Pharmaceuticals Group, Inc. (6)
Boston Therapeutics, Inc. (13)
Bristol-Myers Squibb (13)
Canbiola, Inc. (31)
Cancer Prevention Pharmaceuticals, Inc. (7)
Cannabics Pharmaceuticals Inc. (6)
CANNAPHARMARX, INC. (2)
CANNAPOWDER, INC. (6)
Canopy Growth Corp (1)
CARDAX, INC. (6)
Celexus, Inc (4)
CELGENE CORP (20)
Cerecor Inc. (2)
Charlotte's Web Holdings, Inc. (2)
CHINA PHARMA HOLDINGS, INC. (3)
Cingulate Inc. (11)
Citius Pharmaceuticals, Inc. (7)
Clever Leaves Holdings Inc. (3)
CLS Holdings USA, Inc. (47)
Cocrystal Pharma, Inc. (9)
COLLEGIUM PHARMACEUTICAL, INC (2)
Columbia Care Inc. (3)
ContraVir Pharmaceuticals, Inc. (3)
Corcept Therapeutics Incorporated (1)
CorMedix Inc. (4)
COSMO VENTURES INC (23)
CUBIST PHARMACEUTICALS INC (2)
Cure Pharmaceutical Holding Corp. (13)
Dova Pharmaceuticals Inc. (1)
Egalet Corp (1)
ELITE PHARMACEUTICALS INC (3)
Eloxx Pharmaceuticals, Inc. (5)
Endexx Corp (7)
Endo International plc (1)
Endo Pharmaceuticals Solutions Inc. (2)
EPIX Pharmaceuticals, Inc. (3)
Eton Pharmaceuticals, Inc. (2)
Evofem Biosciences, Inc. (14)
Evolus, Inc. (3)
Exactus, Inc. (11)
EYENOVIA, INC. (1)
FERMAVIR PHARMACEUTICALS, INC. (2)
Furiex Pharmaceuticals, Inc. (1)
Gala Pharmaceutical Inc. (1)
GB SCIENCES INC (28)
GENAISSANCE PHARMACEUTICALS INC (1)
GREEN HYGIENICS HOLDINGS INC. (5)
Green Thumb Industries Inc. (2)
GridIron BioNutrients, Inc. (11)
GUILFORD PHARMACEUTICALS INC (1)
HARROW HEALTH, INC. (4)
Haymaker Acquisition Corp. III (1)
HERATSI PHARMACEUTICALS (2)
Horizon Pharma plc (1)
iANTHUS CAPITAL HOLDINGS, INC. (1)
IMAGING3 INC (19)
INNOVATE BIOPHARMACEUTICALS, INC. (10)
Innoviva, Inc. (2)
IntelGenx Technologies Corp. (6)
Intersect ENT, Inc. (1)
ISTA PHARMACEUTICALS INC (1)
Iterum Therapeutics plc (1)
Jaguar Health, Inc. (27)
Jazz Pharmaceuticals plc (3)
Jiangbo Pharmaceuticals, Inc. (1)
Johnson & Johnson (14)
Journey Medical Corp (1)
JUNIPER PHARMACEUTICALS INC (3)
Jushi Holdings Inc. (1)
Kannalife Inc (5)
Kaya Holdings, Inc. (6)
Kedem Pharmaceuticals Inc. (4)
KEMPHARM, INC (6)
KID CASTLE EDUCATIONAL CORP (2)
Level Brands, Inc. (5)
Lilly (Eli) & Co. (19)
LIPELLA PHARMACEUTICALS INC (3)
Lotus Pharmaceuticals, Inc. (1)
Luckwel Pharmaceuticals Inc. (1)
Mallinckrodt (9)
Marijuana Co of America, Inc. (3)
MedGen, Inc. (6)
Medicine Man Technologies, Inc. (9)
MedMen Enterprises, Inc. (3)
Merck (49)
MICROCHANNEL TECHNOLOGIES CORP (25)
Milestone Pharmaceuticals Inc. (2)
MJ BIOTECH, INC. (3)
MJ Holdings, Inc. (10)
Mylan N.V. (3)
MYnd Analytics, Inc. (68)
NAREK PHARMACEUTICALS (2)
NEKTAR THERAPEUTICS (5)
Neos Therapeutics, Inc. (7)
Neuralstem, Inc. (1)
NEW RIVER PHARMACEUTICALS INC (1)
NewBridge Global Ventures, Inc. (10)
NEXIEN BIOPHARMA, INC. (9)
Notis Global, Inc. (23)
NovaBay Pharmaceuticals, Inc. (12)
Novan, Inc. (2)
NPS PHARMACEUTICALS INC (1)
OCULAR THERAPEUTIX, INC (2)
OMEROS CORP (10)
Omthera Pharmaceuticals, Inc. (1)
One World Pharma, Inc. (14)
ONYX PHARMACEUTICALS INC (2)
OPIANT PHARMACEUTICALS, INC. (1)
OptiNose, Inc. (2)
ORAMED PHARMACEUTICALS INC. (3)
OSCIENT PHARMACEUTICALS CORP (2)
Osmotica Pharmaceuticals plc (3)
Pacira Pharmaceuticals, Inc. (1)
Panacea Acquisition Corp (3)
Paratek Pharmaceuticals, Inc. (1)
PaxMedica, Inc. (7)
PEAK PHARMACEUTICALS, INC. (21)
Perrigo (4)
PetLife Pharmaceuticals, Inc. (1)
Petros Pharmaceuticals, Inc. (2)
Pfizer (3)
Pharmagreen Biotech Inc. (4)
Phathom Pharmaceuticals, Inc. (2)
Phoenix Life Sciences International Limited. (1)
Planet 13 Holdings Inc. (3)
PLAYERS NETWORK (37)
PONIARD PHARMACEUTICALS, INC. (2)
Prestige Brands Holdings Inc (1)
Processa Pharmaceuticals, Inc. (4)
ProPhase Labs, Inc. (7)
PROVECTUS BIOPHARMACEUTICALS, INC. (14)
QUANTA INC (4)
RADIENT PHARMACEUTICALS Corp (10)
Rani Therapeutics Holdings, Inc. (1)
Recro Pharma, Inc. (3)
Reliant Pharmaceuticals, Inc. (2)
RELMADA THERAPEUTICS, INC. (1)
RespireRx Pharmaceuticals Inc. (27)
Revance Therapeutics, Inc. (1)
Rib-X Pharmaceuticals, Inc. (11)
ROCK CREEK PHARMACEUTICALS, INC. (3)
SALIX PHARMACEUTICALS LTD (6)
SCYNEXIS INC (3)
Semnur Pharmaceuticals, Inc. (1)
SenesTech, Inc. (1)
SHAMAN PHARMACEUTICALS INC (1)
SIGA TECHNOLOGIES INC (4)
Sucampo Pharmaceuticals, Inc. (3)
Sunset Island Group (5)
Supernus Pharmaceuticals, Inc. (2)
SYNERGY PHARMACEUTICALS, INC. (2)
Synovics Pharmaceuticals (2)
TAPESTRY PHARMACEUTICALS, INC (1)
Target Group Inc. (5)
Targeted Medical Pharma, Inc. (1)
TAURIGA SCIENCES, INC. (76)
Tenzing Acquisition Corp. (8)
Terra Tech Corp. (54)
TETRALOGIC PHARMACEUTICALS CORP (6)
TETRAPHASE PHARMACEUTICALS INC (1)
Textmunication Holdings, Inc. (31)
THAR PHARMACEUTICALS INC (2)
TherapeuticsMD, Inc. (28)
Theravance Biopharma, Inc. (2)
Thomas Pharmaceuticals, Ltd. (2)
Tilray, Inc. (12)
TILT Holdings Inc. (14)
TITAN PHARMACEUTICALS INC (3)
Tribute Pharmaceuticals Canada Inc. (7)
Trulieve Cannabis Corp. (2)
United Cannabis Corp (6)
Upjohn Inc (1)
Urigen Pharmaceuticals, Inc. (6)
Vallon Pharmaceuticals, Inc. (5)
VASO ACTIVE PHARMACEUTICALS INC (1)
Verano Holdings Corp. (3)
VERBENA PHARMACEUTICALS INC (2)
VIA Pharmaceuticals, Inc. (10)
VION PHARMACEUTICALS INC (1)
VioQuest Pharmaceuticals, Inc. (3)
Vireo Health International, Inc. (1)
Virpax Pharmaceuticals, Inc. (16)
Vitality Biopharma, Inc. (3)
VIVUS INC (3)
WEED, INC. (2)
XERIS PHARMACEUTICALS INC (1)
Zoetis (4)
ZOGENIX, INC. (1)
Zomedica Pharmaceuticals Corp. (2)

Recent Contracts

Category

Company

Industry

Jur. Jurisdiction

Filed

8% Fixed Promissory Note, dated July 28, 2020, in favor of White Lion Capital, LLC

Note Agreements

RespireRx Pharmaceuticals Inc.

Pharmaceuticals

CA

2020

Form of Convertible Promissory Note

Note Agreements

Kaya Holdings, Inc.

2024

Form of Note

Note Agreements

Biofrontera Inc.

2024

Secured Demand Promissory Note dated August 23, 2024 issued to Pasquale Ferro

Note Agreements

Canbiola, Inc.

2024

Third Amendment to Secured Promissory Note, dated November 13, 2024

Note Agreements

Charlotte's Web Holdings, Inc.

2024

Second Amended and Restated Convertible Promissory Note, dated as of April 2, 2024, issued by Denali Capital Acquisition Corp. to Denali Capital Global Investments LLC

Note Agreements

Semnur Pharmaceuticals, Inc.

2024

Secured Promissory Note, dated as of November 5, 2024, between NovaBay Pharmaceuticals, Inc., as borrower, and PRN Physician Recommended Nutriceuticals, LLC, as lender

Note Agreements

NovaBay Pharmaceuticals, Inc.

2024

Promissory Note dated October 28, 2024 from Iterum Therapeutics International Limited to Pfizer Inc

Note Agreements

Iterum Therapeutics plc

2024

Convertible Promissory Note dated October 3, 2024 issued to Quick Capital, LLC

Note Agreements

NEXIEN BIOPHARMA, INC.

2024

Note Purchase Agreement dated October 3, 2024 between the Company and Quick Capital, LLC

Note Agreements

NEXIEN BIOPHARMA, INC.

2024

Promissory note in the amount of $23,791,657 payable by Aphria Diamond Inc

Note Agreements

Tilray, Inc.

2024

Subsidiary Guarantee Amendment, dated October 8, 2024, made by certain of Scilex Holding Company subsidiaries in favor of the holders of that certain Tranche A Note

Note Agreements

ORAMED PHARMACEUTICALS INC.

2024

Tranche B Senior Secured Convertible Note, dated October 8, 2024, issued by Scilex Holding Company to the Company

Note Agreements

ORAMED PHARMACEUTICALS INC.

2024

Amended Amendment to the June 2022 Promissory Note by and between Apimeds Pharmaceuticals US, Inc. and Inscobee Inc., dated June 12, 2024

Note Agreements

Apimeds Pharmaceuticals US, Inc.

2024

Convertible Note Assignment Agreement (March 2022 Promissory Note), by and between Apimeds Pharmaceuticals US, Inc., Apimeds, Inc., and Inscobee Inc., dated June 12, 2024

Note Agreements

Apimeds Pharmaceuticals US, Inc.

2024

Convertible Note Assignment Agreement (August 2021 Promissory Note), by and between Apimeds Pharmaceuticals US, Inc., Apimeds, Inc., and Inscobee Inc., dated June 12, 2024

Note Agreements

Apimeds Pharmaceuticals US, Inc.

2024

May 2024 Promissory Note by and between Apimeds Pharmaceuticals US, Inc. and Inscobee Inc., dated May 20, 2022

Note Agreements

Apimeds Pharmaceuticals US, Inc.

2024

Amendment to the June 2022 Promissory Note by and between Apimeds Pharmaceuticals US, Inc. and Inscobee Inc., dated December 5, 2023

Note Agreements

Apimeds Pharmaceuticals US, Inc.

2024

June 2022 Promissory Note by and between Apimeds Pharmaceuticals US, Inc. and Inscobee Inc., dated June 3, 2022

Note Agreements

Apimeds Pharmaceuticals US, Inc.

2024

Amendment to the March 2022 Promissory Note by and between Apimeds Pharmaceuticals US, Inc. and Apimeds Inc., dated December 5, 2023

Note Agreements

Apimeds Pharmaceuticals US, Inc.

2024

March 2022 Promissory Note by and between Apimeds Pharmaceuticals US, Inc. and Apimeds Inc., dated March 21, 2022

Note Agreements

Apimeds Pharmaceuticals US, Inc.

2024

Amendment to the August 2021 Promissory Note by and between Apimeds Pharmaceuticals US, Inc. and Apimeds Inc., dated December 5, 2023

Note Agreements

Apimeds Pharmaceuticals US, Inc.

2024

August 2021 Promissory Note by and between Apimeds Pharmaceuticals US, Inc. and Apimeds Inc., dated August 30, 2021

Note Agreements

Apimeds Pharmaceuticals US, Inc.

2024

Amended Convertible Promissory Note made by CLS Holdings, Inc. in favor of FK Legacy Trust

Note Agreements

CLS Holdings USA, Inc.

2024

Convertible Promissory Note to FK Legacy Trust ($2,600,000)

Note Agreements

CLS Holdings USA, Inc.

2024

Promissory Note dated March 15, 2024

Note Agreements

MYnd Analytics, Inc.

2024

Form of Promissory Note from SFL Investment Holdings, LLC and Mint Florida Holdings, LLC

Note Agreements

Columbia Care Inc.

2024

Verano Holdings, LLC Promissory Note

Note Agreements

Verano Holdings Corp.

2024

Verano Holdings, LLC Promissory Note

Note Agreements

Columbia Care Inc.

2024

Amended and Restated Unsecured Promissory Note and Guaranty issued to JXVII Trust, dated August 15, 2024

Note Agreements

ProPhase Labs, Inc.

2024

Promissory note, dated August 16, 2024, issued to Citius Pharmaceuticals, Inc. by Citius Oncology, Inc

Note Agreements

Citius Pharmaceuticals, Inc.

2024

Form of Officers Certificate setting forth the terms and form of the Notes

Note Agreements

Lilly (Eli) & Co.

2024

Form of Senior Secured Convertible Promissory Note to be issued by the Company pursuant to and in accordance with the Securities Purchase Agreement

Note Agreements

Big Rock Partners Acquisition Corp.

2024

Form of Senior Secured Convertible Promissory Note due February 15, 2026

Note Agreements

Angion Biomedica Corp.

2024

Secured Promissory Note, dated May 2, 2024, by and between Standard Farms LLC and Lender

Note Agreements

TILT Holdings Inc.

2024

Form of Verano Holdings, LLC Promissory Note

Note Agreements

Verano Holdings Corp.

2024

Form of Verano Holdings, LLC Promissory Note

Note Agreements

Columbia Care Inc.

2024

Form of Senior Unsecured Nonconvertible Note

Note Agreements

ContraVir Pharmaceuticals, Inc.

2024

Form of Unsecured Convertible Promissory Note

Note Agreements

PROVECTUS BIOPHARMACEUTICALS, INC.

2024

Amendment No. 8 to Convertible Promissory Note, by and between Seelos Therapeutics, Inc. and Lind Global Asset Management V, LLC, effective July 16, 2024

Note Agreements

APRICUS BIOSCIENCES, INC.

2024

First Amendment to Promissory Note dated July 3, 2024, by and among Medicine Man Technologies, Inc. a Nevada Corporation, Nuevo Holdco, LLC a New Mexico limited liability company...

Note Agreements

Medicine Man Technologies, Inc.

2024